Ryszard Smolarczyk Selected Research

D-K6L9 peptide

8/2014

D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryszard Smolarczyk Research Topics

Disease

27	Neoplasms (Cancer) 08/2021 - 03/2005
18	Melanoma (Melanoma, Malignant) 08/2021 - 01/2006
4	Hypoxia (Hypoxemia) 01/2021 - 01/2018
3	Necrosis 08/2021 - 04/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2006
1	Multiple Myeloma 01/2021
1	Vascular Tissue Neoplasms 06/2020
1	Peripheral Arterial Disease 11/2019
1	Carcinoma (Carcinomatosis) 02/2019
1	Nasopharyngeal Carcinoma 06/2010
1	Hemolysis 06/2010
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2005
1	Cystic Fibrosis (Mucoviscidosis) 03/2005

Drug/Important Bio-Agent (IBA)

6	Interleukin-12 (IL 12)IBA 01/2021 - 06/2010
6	Peptides (Polypeptides)IBA 11/2016 - 01/2006
4	Pharmaceutical PreparationsIBA 06/2021 - 01/2012
4	Therapeutic UsesIBA 01/2021 - 05/2006
3	vadimezanIBA 08/2021 - 01/2018
3	EnzymesIBA 12/2020 - 12/2006
3	CytokinesIBA 04/2014 - 05/2006
3	DNA (Deoxyribonucleic Acid)IBA 06/2010 - 03/2005
2	Oxygen (Dioxygen)IBA 01/2021 - 06/2019
2	Heme Oxygenase-1IBA 12/2020 - 12/2006
2	VaccinesIBA 06/2020 - 12/2015
2	Digoxin (Digitek)FDA LinkGeneric 03/2020 - 01/2018
2	Folic Acid (Vitamin M)FDA LinkGeneric 02/2019 - 06/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 06/2010
2	ProdrugsIBA 01/2014 - 07/2009
2	hydrazine (hydrazine dihydrochloride)IBA 01/2014 - 07/2009
2	Proteins (Proteins, Gene)FDA Link 11/2012 - 07/2009
2	HMGB1 Protein (HMG1)IBA 11/2012 - 10/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 05/2006
1	FlavonoidsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	daratumumabIBA 01/2021
1	betulinIBA 02/2019
1	Phosphates (Orthophosphate)IBA 02/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	EndoglinIBA 01/2018
1	DNA VaccinesIBA 01/2018
1	glutaminyl- arginyl- phenylalanyl- seryl- arginineIBA 11/2016
1	sialorphinIBA 11/2016
1	Antimicrobial PeptidesIBA 11/2016
1	Heat Shock Transcription FactorsIBA 02/2015
1	VinculinIBA 02/2015
1	D-K6L9 peptideIBA 08/2014
1	PhosphatidylserinesIBA 08/2014
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 08/2014
1	InterleukinsIBA 04/2014
1	Recombinant ProteinsIBA 04/2014
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2014
1	Melphalan (Alkeran)FDA LinkGeneric 01/2014
1	vasostatinIBA 01/2012
1	Liposomes (Liposome)IBA 06/2010
1	OligopeptidesIBA 06/2010
1	Antineoplastic Agents (Antineoplastics)IBA 07/2009
1	Monophenol Monooxygenase (Tyrosinase)IBA 07/2009
1	Carbidopa (Lodosyn)FDA LinkGeneric 07/2009
1	Levodopa (L Dopa)FDA LinkGeneric 07/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2006
1	Integrin alphaVbeta3IBA 01/2006
1	AlbuminsIBA 03/2005

Therapy/Procedure

16	Therapeutics 06/2021 - 01/2006
4	Radiotherapy 08/2021 - 01/2018
3	Brachytherapy 08/2021 - 06/2020
1	Donor Selection 01/2021
1	Immunotherapy 01/2021
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Drug Therapy (Chemotherapy) 01/2018
1	Injections 06/2010
1	Subcutaneous Injections 12/2006